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TO THE EDITORSympathetic and
Autonomic Effects of
Renal Denervation on
Atrial Remodeling and
Atrial ArrhythmiasI read the article by Schirmer et al. (1) with great in-
terest and congratulate the authors on their excellent
work. As the authors correctly state, there is a direct,
partly blood pressure (BP)–independent effect of renal
denervation (RDN) on cardiac remodeling and the
occurrence of premature atrial contractions. However,
I would like to call attention to a point that needs
further clariﬁcation. RDN reduces renal efferent and
possibly also afferent sympathetic activity, but
compared with beta-blocker treatment, RDN results in
an even more pronounced attenuation of atrial effec-
tive refractory period (AERP) shortening during nega-
tive thoracic pressure in obstructive sleep apnea (2).
Moreover, both increased sympathetic and vagal nerve
discharges before the onset of atrial arrhythmias (3)
and increased sympathetic and parasympathetic nerve
growth in the left atrium are present in pacing-induced
congestive heart failure (4). Both acute autonomic
activation–induced electrophysiological changes and
autonomic remodeling–associated atrial structural
changes may play a signiﬁcant role in the creation of
atrial ectopies and atrialﬁbrillation substrates (4). RDN
reduces atrial sympathetic nerve sprouting, structural
alterations, and AF complexity in persistent AF, inde-
pendent of changes in blood pressure (5), but RDN
might reduce arrhythmogenic atrial autonomic
signaling and structural alterations (4). Modulation of
the autonomic system by RDN already shows prom-
ising results (2). I would like to point out that the au-
thors reported no relationships withmodulation of the
autonomic system.*Salvatore Patanè, MD
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Arrhythm Electrophysiol 2015;8:466–74.REPLY: Sympathetic and Autonomic Effects
of Renal Denervation on Atrial Remodeling
and Atrial ArrhythmiasWe thank Dr. Patanè for his interest and his valuable
comments on our paper (1). He argues that, despite
the attenuation of atrial arrhythmogenic structural
remodeling after renal denervation (RDN) shown in
our paper (1), sympathetic modulation by RDN may
also affect atrial electrophysiology and arrhythmo-
genesis. This point is interesting but, unfortunately,
beyond the scope of our paper. A combined
sympatho-vagal activation rather than sympathetic
or parasympathetic activation alone plays a relevant
role for the initiation and progression of atrial ﬁbril-
lation (AF). RDN affects nerves along the renal
arteries, thus reducing efferent and afferent sympa-
thetic nerve activity. However, the parasympathetic
nervous system is not directly modulated by RDN
because parasympathetic nerves do not run along the
renal arteries. Recently, we showed that RDN reduces
atrial sympathetic but not vagal nerve sprouting,
which resulted in lower complexity of AF in goats (2).
Dr. Patanè mentions our recent observations that
RDN can suppress vagally mediated shortening in
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1639atrial repolarization and increased AF inducibility in
a pig model for sleep apnea, indicating an interac-
tion between the acetylcholine (ACh)-induced atrial
effective refractory period shortening and the re-
duced activation of the sympathetic nervous system
after RDN. Consistently, ACh-mediated AF was facil-
itated by isoproterenol, which decreased the thres-
hold of ACh concentration for AF induction and
increased AF duration in dogs (3).
The proposal to combine different approaches to
modulate the autonomic nervous system is indeed
attractive. However, pre-clinical studies indicate that
the inﬂuence of autonomic nervous system modula-
tion on AF is complex and does not automatically
result in antiarrhythmic effects. As an example, baro-
receptor stimulation at an intensity that reduces heart
rate increases AF susceptibility (4), whereas low-level
stimulation can display antiarrhythmic effects (5).
Whether a combination of 2 approaches to modulate
the autonomic systems results in antiarrhythmic or
arrhythmogenic effects is difﬁcult to predict and
needs to be elucidated in future studies.*Stephan H. Schirmer, MD, PhD
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31:767–74.Post-Percutaneous
Coronary Intervention
Angina
A New Performance Measure?The recently published DUTCH PEERS (DUrable
polymer-based sTent CHallenge of Promus Element
Versus ReSolute Integrity; TWENTE II trial (1) utilizes
an important endpoint for percutaneous coronary
intervention (PCI) studies: “post-PCI angina.” We
congratulate the authors for reporting this important
outcome. This comparative effectiveness study eval-
uated 2 third-generation drug-eluting stents (DES)
with respect to this patient-reported outcome mea-
sure (PROM). At 1-year follow-up, there was no
difference between treatments, with over 80% of
patients in both groups being angina-free. This com-
pares favorably with other PCI studies reporting this
PROM, including the COURAGE (Clinical Outcomes
Utilizing Revascularization and Aggressive DruG
Evaluation) (2) (57%), SYNTAX (Synergy between
PCI with Taxus and Cardiac Surgery) (3) (72%), and
FREEDOM (Future Revascularization Evaluation in
Patients with Diabetes Mellitus: Optimal Manage-
ment of Multivessel Disease) (4) (79%) trials. If post-
PCI angina is to become a commonly reported
PROM, a better understanding of its determinants is
required.
Variability in the post-PCI angina outcome may
arise from differences in patient, angiographic, inter-
ventional, and measurement factors. Patient factors
include risk factors such as diabetes (where angina
sensation is impaired), the clinical presentation (post-
PCI angina may be less common in acute coronary
syndromes), and the baseline angina frequency.
Angiographic and interventional factors that describe
the extent of coronary artery disease and complete-
ness of revascularization are also important. Whether
it is a coincidental observation or an important
determinant, the type of stent may be relevant
because the COURAGE, SYNTAX, FREEDOM, and
DUTCH PEERS studies represent a transition from
bare-metal stents to ﬁrst- and second-generation DES,
respectively, with reports of increasing angina-free
status at 12 months.
Measurement factors for the assessment of post-
PCI angina are especially important and worthy of
further consideration in interpreting the DUTCH
PEERS study. First, ensuring that the measure is
“patient-reported” rather than “clinician-reported”
is important because these have been shown to
